EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 241 filers reported holding EDITAS MEDICINE INC in Q3 2020. The put-call ratio across all filers is 0.58 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,272,768 | -8.7% | 1,702,030 | -3.7% | 0.00% | -20.0% |
| Q2 2023 | $14,544,015 | +24.5% | 1,767,229 | +9.6% | 0.01% | +25.0% |
| Q1 2023 | $11,684,443 | +79739.0% | 1,611,753 | -2.3% | 0.00% | 0.0% |
| Q4 2022 | $14,635 | -99.8% | 1,650,010 | +151.3% | 0.00% | +33.3% |
| Q3 2022 | $8,035,000 | -2.3% | 656,502 | -5.5% | 0.00% | 0.0% |
| Q2 2022 | $8,222,000 | -50.1% | 695,058 | -19.8% | 0.00% | -40.0% |
| Q1 2022 | $16,490,000 | -30.1% | 866,915 | -2.4% | 0.01% | -28.6% |
| Q4 2021 | $23,589,000 | -19.1% | 888,374 | +25.2% | 0.01% | -22.2% |
| Q3 2021 | $29,160,000 | -18.1% | 709,766 | +12.8% | 0.01% | -18.2% |
| Q2 2021 | $35,605,000 | +215.1% | 629,031 | +133.8% | 0.01% | +175.0% |
| Q1 2021 | $11,298,000 | +45.8% | 269,028 | +143.4% | 0.00% | +33.3% |
| Q4 2020 | $7,748,000 | +1398.6% | 110,518 | +500.3% | 0.00% | – |
| Q3 2020 | $517,000 | – | 18,410 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Deep Track Capital, LP | 7,101,935 | $55,395,093 | 2.14% |
| Green Alpha Advisors, LLC | 77,188 | $602,066 | 0.46% |
| Woodline Partners LP | 3,259,710 | $25,425,738 | 0.30% |
| TANG CAPITAL MANAGEMENT LLC | 200,000 | $1,560,000 | 0.22% |
| Spectrum Planning & Advisory Services Inc. | 14,038 | $109,496 | 0.17% |
| PDT Partners, LLC | 156,515 | $1,220,817 | 0.15% |
| CALTON & ASSOCIATES, INC. | 13,420 | $104,676 | 0.15% |
| Corton Capital Inc. | 29,365 | $229,047 | 0.12% |
| CAXTON ASSOCIATES LP | 61,223 | $477,539 | 0.07% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 119,287 | $930,439 | 0.06% |